BREAKING: Crude Oil Jumps 5% On Trump Move Medpace stock rocketed early Thursday on "another strong Q," that included double-digit sales and profit growth and a guidance hike. "There's no other term of describe the Medpace quarter than another solid beat that included another guidance raise," Leerink Partners analyst Michael Cherny said in a report. "The quarter saw solid pull-through on better revenue, while the new bookings outpaced our/investor expectations, and the company's 1.20x book-to-bill outpaced ...